were kids in the recent generation raised on prescribed amphetamines?
“we had a generation of kids raised on amphetamines.”
a host said on Huberman Lab, 2026-09-21, at 2:15:25. hear it in context →
first, the part that holds
millions of american children take prescription adhd medication, and amphetamine products are one of the two main stimulant families they get. in commercially insured claims, about 1 in 10 boys aged 10-14 filled a stimulant prescription in a single year.
what we found when we went and looked
we went and looked at the national survey and claims data. across all children aged 3-17, parent-reported adhd medication use was 5.4% in 2016 and 5.5% in 2023 (national survey of children's health, 282,720 children). that figure counts every adhd medication, including methylphenidate and nonstimulants, and the studies we read found methylphenidate, not amphetamine, was the drug most often prescribed to school-age children. stimulant fills among commercially insured children held flat or fell from 2016 to 2021. a real and sizable minority, yes. a generation raised on amphetamines, the record does not show.
assertion by assertion
| assertion | verdict | what the record says |
|---|---|---|
| a large share of children in the recent generation take prescribed adhd stimulant medication | overstated | 5.5% of all us children aged 3-17 got adhd medication in 2023 (5.4% in 2016), going by parent report in the national survey of children's health. in 2021 commercial claims, the share with at least one stimulant fill in the year was 9.9% for boys 10-14, 6.7% for boys 5-9, 5.2% for girls 10-14 and 2.9% for girls 5-9. these are single-year figures, so the share ever medicated during childhood will be higher, but none of the sources we read measures that [1][2] |
| the medications those children were raised on are amphetamines | misattributed | the medication figures cover all adhd drugs or all stimulants together: amphetamine and mixed amphetamine salts, lisdexamfetamine, dextroamphetamine, methylphenidate and dexmethylphenidate. in national survey data from 2015 and 2017, methylphenidate was the drug most often prescribed to children and adolescents with adhd, with amphetamine-dextroamphetamine second. in california dispensing data for 2019-2021, methylphenidate led among ages 6-17, and mixed amphetamine salts led only among young adults. none of the sources we read gives a figure for children on amphetamine alone [2][4][5] |
| child adhd medication use has been climbing in recent years | false | between 2016 and 2023, the share of all children on adhd medication did not rise significantly (5.4% to 5.5%), and the share of diagnosed children on medication fell from 62.5% to 53.0%. cdc claims data describe child stimulant use as stable or declining from 2016 to 2021 while adult use rose. these sources start in 2016, so earlier decades are not covered [1][2] |
| adhd diagnosis among us children is common and has grown | confirmed | cdc reports an estimated 7 million children aged 3-17 (11.7%) with a current adhd diagnosis in 2024. in the national survey, diagnosis rose from 8.7% in 2016 to 10.5% in 2023 [1][3] |
both directions
for the speaker: the speaker is right that this is not rare. about 1 child in 18 got adhd medication in a single year, and boys aged 10-14 with commercial insurance reached roughly 1 in 10 in a year. because these are single-year snapshots, the share of a birth cohort that took a stimulant at some point in childhood is higher than any one year's figure. diagnosis has grown to 11.7% of children, and amphetamine-family drugs (mixed amphetamine salts, lisdexamfetamine) are the second most common stimulant for children and the most common among older adolescents and young adults.
against: "a generation" points to a majority or near-majority, but the measured share of all children in any year is about 5-6%. the number is also a class rollup: it counts methylphenidate, which was the most-prescribed drug for school-age children in both datasets we read, plus nonstimulants, so labeling all of it "amphetamines" assigns the figure to the wrong drug. for the recent period, use was flat, not rising: all-children medication use barely moved from 2016 to 2023, the share of diagnosed children medicated fell, and cdc's claims analysis found the growth in stimulant use among adults, not children.
what this cannot say
the national survey relies on parent report and asks about current or past-year medication, not lifetime exposure. we found no primary source in this session that gives cumulative childhood stimulant exposure for a birth cohort, which is the number that would best test "raised on." the claims data cover employer-insured families only, leaving out medicaid, where pediatric rates may differ. none of the sources we read reports a child-specific amphetamine share. the class-split studies are older (2015/2017 national survey, small samples) or limited to california. our trend sources start in 2016, so we did not test the rise in the 1990s and 2000s that the speaker's generation would also span.
sources, each one fetched and read
- cdc and hrsa researchers, "Trends in Parent-Reported ADHD Diagnosis and Treatment Among U.S. Children, 2016–2023," Journal of Clinical Child & Adolescent Psychology, 2026, doi:10.1080/15374416.2026.2620385 What we read there: adhd diagnosis 8.7% (2016) to 10.5% (2023); medication treatment among all children 5.4% to 5.5%, not a significant increase; among diagnosed children medication treatment fell from 62.5% to 53.0%; n = 282,720 Fetched 2026-10-28 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC13132157/
- CDC, "Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults — United States, 2016–2021," MMWR 72(13), 2023 What we read there: share with at least one stimulant fill, 2016 to 2021: males 5-9 7.3% to 6.7%, males 10-14 10.8% to 9.9%, females 5-9 3.0% to 2.9%, females 10-14 4.8% to 5.2%; stimulants analyzed together (amphetamine, mixed salts, dextroamphetamine, lisdexamfetamine, methylphenidate, dexmethylphenidate, methamphetamine) Fetched 2026-10-28 (HTTP 200). https://www.cdc.gov/mmwr/volumes/72/wr/mm7213a1.htm
- CDC, Data and Statistics on ADHD in Children (updated July 2026) What we read there: an estimated 7 million (11.7%) U.S. children aged 3–17 years have a current ADHD diagnosis, per 2024 national survey of parents Fetched 2026-10-28 (HTTP 200). https://www.cdc.gov/adhd/data/index.html
- "Patterns of Medication Prescription among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United States," Children (Basel), 2022 (Medical Expenditure Panel Survey 2015 and 2017) What we read there: among children and adolescents with adhd, methylphenidate was the most prescribed medication; amphetamine-dextroamphetamine was the second most common stimulant Fetched 2026-10-28 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC8870051/
- "Changes in real-world dispensing of ADHD stimulants in youth from 2019 to 2021 in California," Frontiers in Public Health, 2024 (CURES prescription monitoring data) What we read there: methylphenidate was primarily prescribed to patients aged 6–17; lisdexamfetamine was predominantly prescribed to adolescents; among young adults the top stimulants dispensed were mixed amphetamine salts Fetched 2026-10-28 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC10948562/
speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam